ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23% Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN …